Competing bills aim for elusive changes to drug discount program
WASHINGTON — A fight over an embattled drug discount program is intensifying on Capitol Hill, as lawmakers weigh competing proposals to reshape the program amid escalating tensions between hospitals and drugmakers. Lawmakers in both chambers have rolled out, or are planning to soon introduce, fresh proposals to alter the 340B program, which requires drug manufacturers sell deeply discounted ...